Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients
Junichiro James Kazama(Japanese Society for Dialysis Therapy), Masafumi Fukagawa(FIND), Fumitake Gejyo(Niigata University of Pharmacy and Medical and Life Sciences), Suguru Yamamoto(Niigata University), Hiroki Maruyama(Niigata University), Takeyoshi Yamashita(Kyowa Kirin (Japan)), Fuminori Sato(Niigata University), Kentaro Omori(Niigata University), Seiji Fukumoto(Tokushima Hospital), Hitomi Hama(Niigata University), Ichiei Narita(Niigata University)
Cited by 132
Related Papers
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
|Journal of Clinical Investigation|2004|1.4k
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
|Kidney International|2017|998
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis
|European Heart Journal|2018|323
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update
|Annals of Internal Medicine|2018|316
CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis.
|American Journal of Roentgenology|1997|296